Stock MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Medical Developments International Limited

Equities

MVP

AU000000MVP2

Market Closed - Australian S.E.
Other stock markets
 07:10:06 08/05/2024 BST 		5-day change 1st Jan Change
0.45 AUD +2.27% Intraday chart for Medical Developments International Limited -2.17% -40.79%
04-29 Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
02-29 Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
MT
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Medical Developments International Limited Discontinues China Clinical Trials
CI
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
Rights Issue: 2 new shares @ 2 AUD for 19 existing shares
FA
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike
MT
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
CI
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited
CI
Medical Developments Secures US FDA Approval for Phase 3 Pain Medication Trial; Shares Surge 30%
MT
Medical Developments International Limited Announces That US Food and Drug Administration Lifts Clinical Hold on Penthrox
CI
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
Medical Developments International Limited Provides Sales Guidance for the Fiscal Year 2022
CI
Medical Developments International Limited Announces Earnings Guidance for the Year Ended June 30, 2021
CI
Medical Developments International : Swings to Loss in July-December 2020
MT
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2020
CI
Medical Developments International Limited Declares No Dividend for the Full Year Ended 30 June 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MVP Stock
  4. News Medical Developments International Limited
  5. Highlights